Learn More
Medchemexpress LLC AGI-5198 | 1355326-35-0 | 99.9% | 462.56 | 50 MG

Supplier: Medchemexpress LLC HY1808250MG
AGI-5198 (IDH-C35) is a potent and selective mutant IDH1R132H inhibitor with an IC50 of 0.07 μM. It is designed for research use only.
- Potent and selective mutant IDH1R132H inhibitor.
- Inhibits mutant IDH1 enzyme in TS603 glioma cells.
- Does not impair colony formation of wild-type IDH1 glioma lines.
- Reverses increased reactive oxygen species, DNA double-strand breaks, and cell death after ionizing radiation in IDH1(R132H) mutated cancer cells.
- Causes significant growth inhibition of human glioma xenografts in vivo.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.